Essential Planning, Llc. Anavex Life Sciences Corp. Transaction History
Essential Planning, Llc.
- $15 Billion
- Q4 2024
A detailed history of Essential Planning, Llc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Essential Planning, Llc. holds 413,088 shares of AVXL stock, worth $3.42 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
413,088Holding current value
$3.42 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
170Shares Held
27.6MCall Options Held
518KPut Options Held
681K-
Black Rock Inc. New York, NY6.39MShares$53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$38.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.07MShares$25.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$15.5 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA913KShares$7.57 Million0.62% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $646M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...